Latest lung cancer Stories
Exploratory Analysis Shows Addition of 600mg Apatorsen to Standard of Care Chemotherapy Resulted in 50 Percent Reduction in Risk of Death in Patients with Lower Performance Status Phase
Recognized for Following Best Practices Guidelines and Commitment to Responsible Screenings Philadelphia, PA (PRWEB) December 18, 2014 Aria Health’s
2014 Auction Honors Legacy of MLB's Monica Barlow WASHINGTON, Dec.
Confirmatory study will assess VolitionRx's proprietary Nucleosomics® platform for non-invasive diagnosis of lung cancer as part of larger ongoing, prospective clinical trial NAMUR, Belgium,
CYRAMZA is the first treatment approved in the U.S. for use in combination with docetaxel in second-line metastatic non-small cell lung cancer INDIANAPOLIS, Dec.
Overall Program Total Near Record $100 million WASHINGTON, Dec.
The FDA has approved the drug Cyramza, to be used in combination with docetexal for the treatment of non-small-cell lung cancer (NSCLC).
RnRMarketResearch.com adds "EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023" to its store.
Ancon Medical Seeks Funding for Revolutionary Screening Technology BLOOMINGTON, Minn., Dec.
Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...
- A person in a secondary role, specifically the second most important character (after the protagonist).
More Images (2 images) »